Page last updated: 2024-09-04

olmesartan and Atrophy

olmesartan has been researched along with Atrophy in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's22 (84.62)24.3611
2020's4 (15.38)2.80

Authors

AuthorsStudies
Cook, DR1
Gabb, GM; Moore, K; Shukla, N1
Ahn, B; Hall, SE; Hinkley, JM; Hyatt, H; Morton, AB; Powers, SK; Smuder, AJ; Sollanek, KJ; Wiggs, MP1
Barbara, G; Bellacosa, L; Capuani, F; Cogliandro, RF; Cremon, C; Marasco, G; Mauloni, PA; Paone, C; Stanghellini, V; Vasuri, F1
Cartee, AK; Oxentenko, AS; Reyes Genere, JP1
Alameldin, M; Ghaith, J; Raslan, IA; Szilagyi, A1
Abu Daya, H; Arguelles-Grande, C; Bhagat, G; DeGaetani, M; Green, PH; Lebwohl, B; Lewis, SK; Tennyson, CA1
Lewin, M; Nielsen, JA; Steephen, A1
David, XR; Haramburu, F; Miremont-Salamé, G; Théophile, H1
Khan, AS; Peter, S; Wilcox, CM1
Janssen, J; Mulder, CJ; Nijeboer, P; van Beurden, YH; Verbeek, WH1
Bibbò, S; Cammarota, G; Gasbarrini, A; Ianiro, G; Montalto, M; Ricci, R1
Llobell, A; Milisenda, JC; Pellicé, M; Téllez, A1
Agudo Fernández, S1
Cano Ruiz, A; Crespo Pérez, L; Téllez Villajos, L1
Cano Ruiz, A; Crespo Pérez, L; Moreira Vicente, V; Téllez Villajos, L1
Cardoso, H; Coelho, R; Macedo, G; Santos-Antunes, J1
Colardelle, P; Ould Sidi Mohamed, M2
Biagi, F; Corazza, GR; Cumetti, D; Luinetti, O; Mugellini, A; Schiepatti, A; Sonzogni, A1
Gonzalo, DH; Martelli, MG; Naik, DK; Pannu, D; Sharma, AK1
Capone, P; Caporaso, N; Imperatore, N; Rispo, A; Tortora, R1
Arnason, T; Igoe, J; Kulai, T; MacIntosh, D1
Machado, I; Maia de Alcántara, F; Martínez de Juan, F; Martínez Lapiedra, C; Reolid, M1
Herman, ML; Kelly, DG; Ludvigsson, JF; Mangan, TF; Murray, JA; Rubio-Tapia, A; Wu, TT1

Reviews

4 review(s) available for olmesartan and Atrophy

ArticleYear
An unusual cause of diarrhoea: case report and literature review of olmesartan-associated enteropathy.
    European journal of gastroenterology & hepatology, 2021, 12-01, Volume: 33, Issue:1S Suppl 1

    Topics: Aged; Atrophy; Celiac Disease; Diarrhea; Humans; Imidazoles; Intestinal Diseases; Male; Tetrazoles; Weight Loss

2021
Systematic review: Sprue-like enteropathy associated with olmesartan.
    Alimentary pharmacology & therapeutics, 2014, Volume: 40, Issue:1

    Topics: Angiotensin II Type 1 Receptor Blockers; Atrophy; Celiac Disease; Diagnosis, Differential; Diarrhea; Duodenum; Humans; Imidazoles; Microvilli; Tetrazoles; Weight Loss

2014
[Non celiac villous atrophy: more confusion or a new syndrome?].
    Medicina clinica, 2015, Feb-02, Volume: 144, Issue:3

    Topics: Atrophy; Autoantibodies; Celiac Disease; Chronic Disease; Collagenous Sprue; Common Variable Immunodeficiency; Diagnosis, Differential; Diarrhea; Duodenum; Enteritis; Enterocytes; Eosinophilia; Gastritis; Humans; Imidazoles; Intestinal Mucosa; Malabsorption Syndromes; Microvilli; Polyendocrinopathies, Autoimmune; Tetrazoles

2015
Duodenal Villous Atrophy in a TTG-Negative Patient Taking Olmesartan: A Case Report and Review of the Literature.
    Canadian journal of gastroenterology & hepatology, 2016, Volume: 2016

    Topics: Aged; Antihypertensive Agents; Atrophy; Biopsy; Collagenous Sprue; Diarrhea; Duodenum; Humans; Hypertension; Imidazoles; Male; Tetrazoles; Vomiting; Weight Loss

2016

Other Studies

22 other study(ies) available for olmesartan and Atrophy

ArticleYear
Olmesartan enteropathy: an important cause of malabsorption and diarrhoea.
    Internal medicine journal, 2020, Volume: 50, Issue:1

    Topics: Antihypertensive Agents; Atrophy; Celiac Disease; Diarrhea; Female; Humans; Hypertension; Imidazoles; Middle Aged; Tetrazoles

2020
Olmesartan-associated duodenal villous atrophy, an emerging clinical issue.
    Internal medicine journal, 2020, Volume: 50, Issue:5

    Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrophy; Humans; Hypertension; Imidazoles; Olmesartan Medoxomil; Tetrazoles

2020
Comparative Efficacy of Angiotensin II Type 1 Receptor Blockers Against Ventilator-Induced Diaphragm Dysfunction in Rats.
    Clinical and translational science, 2021, Volume: 14, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Atrophy; Diaphragm; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Imidazoles; Irbesartan; Rats; Respiration, Artificial; Tetrazoles; Ventilators, Mechanical

2021
New Onset Villous Atrophy in a Patient With Celiac Disease.
    Gastroenterology, 2018, Volume: 155, Issue:4

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrophy; Biopsy; Celiac Disease; Collagenous Sprue; Diet, Gluten-Free; Female; Humans; Hypertension; Imidazoles; Intestine, Small; Medication Therapy Management; Microvilli; Risk Factors; Tetrazoles

2018
Case of olmesartan-associated enteropathy and transient positive antitissue transglutaminase serology.
    BMJ case reports, 2018, Dec-13, Volume: 11, Issue:1

    Topics: Antibodies; Antihypertensive Agents; Atrophy; Celiac Disease; Diagnosis, Differential; Female; Humans; Imidazoles; Intestine, Small; Middle Aged; Tetrazoles; Transglutaminases

2018
Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma.
    The American journal of gastroenterology, 2013, Volume: 108, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Atrophy; Autoantibodies; Biopsy; Celiac Disease; Databases, Factual; Duodenum; Female; HLA-DQ Antigens; Humans; Imidazoles; Immunoglobulins; Immunosuppressive Agents; Intestinal Mucosa; Male; Middle Aged; Retrospective Studies; Tetrazoles

2013
Angiotensin-II inhibitor (olmesartan)-induced collagenous sprue with resolution following discontinuation of drug.
    World journal of gastroenterology, 2013, Oct-28, Volume: 19, Issue:40

    Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrophy; Biopsy; Collagenous Sprue; Duodenoscopy; Duodenum; Female; Humans; Imidazoles; Middle Aged; Regeneration; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome

2013
Five cases of sprue-like enteropathy in patients treated by olmesartan.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2014, Volume: 46, Issue:5

    Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Atrophy; Colitis; Dehydration; Diarrhea; Duodenum; Endoscopy, Gastrointestinal; Female; Humans; Ileitis; Imidazoles; Male; Tetrazoles; Weight Loss

2014
Olmesartan-induced enteropathy resembling celiac disease.
    Endoscopy, 2014, Volume: 46 Suppl 1 UCTN

    Topics: Aged; Antihypertensive Agents; Atrophy; Capsule Endoscopy; Celiac Disease; Diagnostic Errors; Duodenal Diseases; Female; Humans; Ileitis; Imidazoles; Intestinal Mucosa; Jejunal Diseases; Tetrazoles

2014
[Diarrhoea and malabsorption due to olmesartan use].
    Nederlands tijdschrift voor geneeskunde, 2014, Volume: 158

    Topics: Antihypertensive Agents; Atrophy; Celiac Disease; Diagnosis, Differential; Diarrhea; Humans; Hypertension; Imidazoles; Male; Middle Aged; Netherlands; Olmesartan Medoxomil; Tetrazoles

2014
Olmesartan: sprue-like enteropathy.
    Prescrire international, 2014, Volume: 23, Issue:148

    Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrophy; Chronic Disease; Diarrhea; Humans; Imidazoles; Intestines; Malabsorption Syndromes; Risk Factors; Tetrazoles; Weight Loss

2014
[Enteropathy associated with chronic use of olmesartan].
    Medicina clinica, 2015, Feb-02, Volume: 144, Issue:3

    Topics: Adenocarcinoma; Aged; Antihypertensive Agents; Atrophy; Celiac Disease; Chronic Disease; Diagnosis, Differential; Diagnostic Errors; Diarrhea; Duodenum; Humans; Hypertension; Imidazoles; Intestinal Mucosa; Malabsorption Syndromes; Male; Microvilli; Prostatectomy; Prostatic Neoplasms; Tetrazoles

2015
[Sprue-like enteropathy due to olmesartan: a case report].
    Gastroenterologia y hepatologia, 2015, Volume: 38, Issue:2

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Atrophy; Celiac Disease; Chronic Disease; Diarrhea; Female; Humans; Hypertension; Imidazoles; Intestinal Mucosa; Microvilli; Tetrazoles

2015
[Enteropathy by olmesartan].
    Medicina clinica, 2015, Feb-02, Volume: 144, Issue:3

    Topics: Aged; Antihypertensive Agents; Atrophy; Celiac Disease; Chronic Disease; Diagnosis, Differential; Diarrhea; Duodenum; Humans; Hypertension; Imidazoles; Immunophenotyping; Intestinal Mucosa; Lymphocyte Subsets; Malabsorption Syndromes; Male; Microvilli; Tetrazoles

2015
Drug-induced small-bowel mucosal atrophy.
    Endoscopy, 2015, Volume: 47 Suppl 1 UCTN

    Topics: Aged; Antihypertensive Agents; Atrophy; Capsule Endoscopy; Chronic Disease; Diarrhea; Duodenum; Humans; Imidazoles; Intestinal Mucosa; Jejunum; Male; Tetrazoles

2015
[Enteropathy due to olmesartan].
    Annales de cardiologie et d'angeiologie, 2016, Volume: 65, Issue:2

    Topics: Antihypertensive Agents; Atrophy; Biopsy; Diarrhea; Duodenitis; Duodenum; Essential Hypertension; Humans; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles; Withholding Treatment

2016
Olmesartan-associated enteropathy: new insights on the natural history? Report of two cases.
    Scandinavian journal of gastroenterology, 2016, Volume: 51, Issue:2

    Topics: Aged; Antihypertensive Agents; Atrophy; Duodenal Diseases; Humans; Imidazoles; Intestinal Mucosa; Male; Middle Aged; Tetrazoles

2016
An atypical case of chronic diarrhoea: olmesartan-induced sprue-like enteropathy.
    BMJ case reports, 2015, Sep-14, Volume: 2015

    Topics: Aged, 80 and over; Atrophy; Celiac Disease; Diarrhea; Female; Humans; Imidazoles; Intestinal Diseases; Intestines; Olmesartan Medoxomil; Tetrazoles

2015
An emerging issue in differential diagnosis of diarrhea: sprue-like enteropathy associated with olmesartan.
    Scandinavian journal of gastroenterology, 2016, Volume: 51, Issue:3

    Topics: Antihypertensive Agents; Atrophy; Celiac Disease; Diagnosis, Differential; Diarrhea; Duodenal Diseases; Humans; Imidazoles; Intestinal Mucosa; Male; Middle Aged; Tetrazoles

2016
[Enteropathy due to olmesartan].
    Annales de cardiologie et d'angeiologie, 2016, Volume: 65, Issue:4

    Topics: Angiotensin II Type 1 Receptor Blockers; Atrophy; Duodenum; Humans; Imidazoles; Intestinal Mucosa; Lymphocytes; Male; Middle Aged; Tetrazoles

2016
Sprue-like enteropathy associated with olmesartan in a patient with villous atrophy, HLA-DQ2 genotype and antinuclear antibodies.
    Revista espanola de enfermedades digestivas, 2016, Volume: 108, Issue:11

    Topics: Aged; Antibodies, Antinuclear; Anticholesteremic Agents; Atrophy; Celiac Disease; Gastrointestinal Diseases; Genotype; HLA-DQ Antigens; Humans; Imidazoles; Male; Tetrazoles

2016
Severe spruelike enteropathy associated with olmesartan.
    Mayo Clinic proceedings, 2012, Volume: 87, Issue:8

    Topics: Abdominal Pain; Aged; Aged, 80 and over; Anemia; Angiotensin II Type 1 Receptor Blockers; Atrophy; Biopsy; Colitis, Microscopic; Collagen; Diarrhea; Fatigue; Female; Gastritis; Hospitalization; Humans; Hypoalbuminemia; Imidazoles; Inflammation; Intestinal Mucosa; Intestines; Lymphocytes; Male; Middle Aged; Nausea; Severity of Illness Index; Stomach; Tetrazoles; Vomiting; Water-Electrolyte Imbalance; Weight Loss; Zinc

2012